Comparative Study of Atorvastatin versus Rosuvastatin in Reducing LDL Cholesterol in Dyslipidemia Patients
International Journal of Current Pharmaceutical Review and Research · 15.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.98 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 15.03.2026. Verfasst von Rashmi Verma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Dyslipidemia is a major risk factor for cardiovascular diseases and is characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C), triglycerides, or reduced high-density lipoprotein cholesterol (HDL-C). Statins remain the cornerstone of pharmacological therapy for dyslipidemia due to their ability to inhibit HMG-CoA reductase and reduce cholesterol synthesis in the liver. Among commonly prescribed statins, atorvastatin and rosuvastatin are widely used due to their potent lipid-lowering effects. Several studies suggest that rosuvastatin may provide greater reductions in LDL-C compared with atorvastatin at equivalent doses.
Aim
To compare the efficacy of atorvastatin and rosuvastatin in reducing LDL cholesterol levels in patients with dyslipidemia. Materials and Methods: A prospective comparative study was conducted among 200 patients with dyslipidemia attending the medicine outpatient department of a tertiary care hospital. Patients were randomly allocated into two groups: Group A (Atorvastatin 20 mg, n=100) and Group B (Rosuvastatin 10 mg, n=100). Baseline lipid profile parameters were recorded and repeated after 12 weeks of therapy. Statistical analysis was performed using Student’s t-test and chi-square test. A p-value
Zitieren
APA
Verma, R., Sen, S., & Nageswararao, M. (2026). Comparative Study of Atorvastatin versus Rosuvastatin in Reducing LDL Cholesterol in Dyslipidemia Patients. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.98
Vancouver
Verma R, Sen S, Nageswararao M. Comparative Study of Atorvastatin versus Rosuvastatin in Reducing LDL Cholesterol in Dyslipidemia Patients. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.98
BibTeX
@article{Verma2026,
author = {Verma, Rashmi and Sen, Shipra and Nageswararao, Mallempati},
title = {Comparative Study of Atorvastatin versus Rosuvastatin in Reducing LDL Cholesterol in Dyslipidemia Patients},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.98}
}
EUVIMED